Diagnostic Domain

While diagnostics are becoming a no-fly zone for many VCs, Domain Associates continues to place bets in the space. The firm participated in a $28 million series C round for Applied Proteomics Inc., which is developing blood-based tests that use mass spectrometry to analyze an individual's proteomic signature.